©The Author(s) 2018.
World J Gastroenterol. Feb 21, 2018; 24(7): 862-869
Published online Feb 21, 2018. doi: 10.3748/wjg.v24.i7.862
Published online Feb 21, 2018. doi: 10.3748/wjg.v24.i7.862
Table 1 Demographic and treatment data (n = 62)
| Characteristics | n (%) | |
| Sex | Female:Male | 4:58 (6.5:93.5) |
| Age | Median 66 yr (range 29-86) | |
| Pathology | Squamous cell carcinoma | 56 (90.3) |
| Adenocarcinoma | 2 (3.2) | |
| Other | 4 (6.5) | |
| T stage | T1 | 14 (22.6) |
| T2 | 6 (9.7) | |
| T3 | 30 (48.4) | |
| T4 | 12 (19.3) | |
| Regional node metastasis | N0 | 14 (22.6) |
| N+ | 48 (77.4) | |
| Tumor length | Median 5.0 cm (range 1-14) | |
| Total length of skip lesions | Median 5.0 cm (range 1-20) | |
| Involved circumference | < 100% | 40 (64.5) |
| 100% | 22 (35.5) | |
| Stenosis at diagnosis | No | 45 (72.6) |
| Yes | 17 (27.4) | |
| Radiation dose (EQD1.8) | Median 63 Gy (range 45-90) | |
| Concurrent chemotherapy | Yes | 60 (96.8) |
| No | 2 (3.2) | |
| Endoscopic response | CR | 39 (62.9) |
| < CR | 23 (37.1) |
- Citation: Kim JW, Kim TH, Kim JH, Lee IJ. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy. World J Gastroenterol 2018; 24(7): 862-869
- URL: https://www.wjgnet.com/1007-9327/full/v24/i7/862.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i7.862